Jagsonpal Pharmaceuticals reports Q2FY23 net profit at Rs. 10.41 Cr
News

Jagsonpal Pharmaceuticals reports Q2FY23 net profit at Rs. 10.41 Cr

The company has reported total income of Rs. 61.64 crores during the period ended September 30, 2022.

  • By IPP Bureau | November 11, 2022

Jagsonpal Pharmaceuticals Limited has posted net profit of Rs. 10.41 crores for the period ended September 30, 2022 as against net profit of Rs. 2.92 crores for the period ended June 30, 2022. The company posted net profit of Rs.6.56 crores for the period ended September 30, 2021.

The company has reported total income of Rs. 61.64 crores during the period ended September 30, 2022 as compared to Rs. 60.91 crores during the period ended June 30, 2022. It reported total income of Rs.58.6779 crores during the period ended September 30, 2021.

For the half year ended September 30, 2022, Jagsonpal Pharmaceuticals has reported total income of Rs.122.55 crores as compared to Rs.113.55 crores during the 6 months period ended September 30, 2021.

The company has posted net profit of Rs.13.33 crores for the 6 months period ended September 30, 2022 as against net profit of Rs.13.14 crores for the 6 months period ended September 30, 2021.

Other Related stories

Startup

Digitization

India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
Sanjay Vyas President and Managing Director, Parexel India And Global SBU Head- Safety services & Logistics, Parexel International